摘要
褪黑素（MLT）,化学名为：N-乙酰-5-甲氧基色胺,因能使蛙皮肤褪色而命名。1958年由Lemer自牛的松果腺中第一次提取出来,其分布和生物学功能也逐步为人们所了解。
出处
《临床合理用药杂志》
2013年第5期179-180,共2页
Chinese Journal of Clinical Rational Drug Use
基金
河北省科技支撑计划项目(课题编号:11276178)
参考文献8
-
1Ackermann K, Bux R, Rub U, et al. Melatonin synthesis in the human pineal gland [ J ]. BMC Neuroscience,2007,8 ( Suppl 1 ) :172.
-
2Sankaran Mirunalini, Kandhan Karthishwaran, Ganesan Dhamodharan, et al. Melatonin attenuates lipid peroxldation and enhances circulatory an- tioxidants during mammary carcinogenesis in rats ,I ]. J Biochem Tech, 2010,2(3) :171 -- 174.
-
3Erkan Yurtcu, Yildiz Guney, Mehmet Ali Ergun, et al. Lack of a time-de- pendent effect of melatonin on radiation-induced apoptosis in cultured rat lymphocytes [ J ]. Cell Biology International,2007,31 (6) : 1144 - 1149.
-
4Geofffiau M, Brun J, Chazot G, et al. The physiology and pharmacology Of melatonin in humans [ J ]. Horm Res, 1998,49 (3 - 4 ) : 136 - 141.
-
5Reiter RJ,Acuna-Castroviejo D,Tan DX,et al. Mechanisms for the pro- tective actions of melatonin in the central nervous system [ J ]. Ann N Y Acad Sci,2002,89 (5) :200 - 215.
-
6Zeitzer JM, Ayas NT, Shea SA, et al. Absence of detectable melatonin and preservation of cortisol and thyrotrop in rhythms intetraplegia [ J ]. J Clin Endocrinol Metab,2000,85(6) :2189 -2196.
-
7Konakehieva R, Miter Y, Almeida OF, et al. Chronic melatonin treatment counteracts glucoeorticoid-induced dysregulation of the hypothlamic-pitu- itary-adrenal axis in the rat [ J]. N, euroendocrinology, 1998,67 ( 3 ) : 171 - 180.
-
8Reiter RJ ,Tan DX ,Terron MP, et al. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions [ J]. Acta Biochem Pol,2007,54( 1 ) :1291.
同被引文献35
-
1李伶俐,林汉华,陈晓娟,夏治,刘方,刘小辉.外源性褪黑素水平对雌性性早熟大鼠的影响[J].实用儿科临床杂志,2007,22(20):1539-1541. 被引量：7
-
2Srinivasan V, Pandi-Perumal SR, Brzezinski A, et al. Melatonin, immune function and cancer[J]. Recent Pat Endocr Metab Immune Drug Discov, 2011, 5(2): 109-123.
-
3Luchetti F, Canonico B, Betti M, et al. Melatonin signaling and cell protection function[J]. FASEB J, 2010, 24(10): 3603-3624.
-
4Mills E, Wu P, Seely D, et al. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta- analysis[J].J Pineal Res, 2005, 39(4): 360-366.
-
5Neri B, de Leonardis V, Gemelli MT, et al. Melatonin as biological response modifier in cancer patients[J]. Anticancer Res, 1998, 18(2B): 1329-1332.
-
6Cos S, Sinchez-Barcel6 EJ. Differences between pulsatile or continuous exposure to melatonin on MCF-7 human breast cancer cell proliferation[J]. Cancer Lett, 1994, 85(1): 105-109.
-
7Vijayalaxmi, Reiter RJ, Meltz ML. Melatonin protects human blood lymphocytes from radiation-induced chromosome damage[J]. Mural Res, 1995, 346(1): 23-31.
-
8Conti A, Maestroni GJ. The clinical neuroimmunotherapeutic role ofmelatonin in oncology[J]. J Pineal Res, 1995, 19(3): 103-110.
-
9Srinivasan V, Spence DW, Pandi-Perumal SR, et al. Therapeutic actions of melatonin in cancer: possible mechanisms[J]. Integr Cancer Ther, 2008, 7(3): 189-203.
-
10Ali AT. Risk factors for endometrial cancer[J]. Ceska Gynekol, 2013, 78(5): 48-59.
